MAPK3 and lung cancer: Previous studies indicate that CCR7-mediated signaling required for invasive and pro-survival functions in head and neck cancer cells is mediated by PI3K/AKT pathway [14], whereas CCR7-mediated cell cycle progression in lung cancer cells utilizes ERK1/2 pathway [39].